ICUCW
SeaStar Medical Holding Corporation
NASDAQ · Healthcare · Biotechnology · US
$0.02
−5.49%Price chart
Aug 18Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18
Key dataSep 18, 2026
Open$0.01
From 52W high−71.77%
Volume1.00
Market cap$40909.77
P/E (TTM)—
P/S (TTM)0.0x
Div yield—
Key dataSep 18, 2026
Open
$0.01
From 52W high
−71.77%
Volume
1.00
Market cap
$40909.77
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.5x
P/E (TTM)
—
RSI (14)
46.0
MomentumView details →
1D Return
−5.49%
YTD Return
+41.59%
Similar companies
Latest newsMore news →
SeaStar Medical Holding Corporation expanded adoption of its QUELIMMUNE product to 20 of 50 premier children's hospitals, targeting 25 by year-end.39d agoSeaStar Medical reported its second quarter 2026 financial results, with net revenue up 82% versus the second quarter of 2025, and added three top-rated children's hospitals to its QUELIMMUNE pediatric acute kidney injury customer base.39d ago